Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Return on Assets (2020 - 2025)

Goldenwell Biotech (GWLL) has disclosed Return on Assets for 6 consecutive years, with 0.1% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets rose 77.0% year-over-year to 0.1%, compared with a TTM value of 0.1% through Sep 2025, up 77.0%, and an annual FY2024 reading of 0.58%, down 9.0% over the prior year.
  • Return on Assets was 0.1% for Q3 2025 at Goldenwell Biotech, up from 0.02% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.1% in Q3 2025 and bottomed at 5.36% in Q3 2023.
  • Average Return on Assets over 5 years is 1.19%, with a median of 0.35% recorded in 2022.
  • The sharpest move saw Return on Assets tumbled -501bps in 2023, then soared 468bps in 2024.
  • Year by year, Return on Assets stood at 0.25% in 2021, then plummeted by -1433bps to 3.83% in 2022, then soared by 85bps to 0.56% in 2023, then soared by 66bps to 0.19% in 2024, then skyrocketed by 150bps to 0.1% in 2025.
  • Business Quant data shows Return on Assets for GWLL at 0.1% in Q3 2025, 0.02% in Q2 2025, and 0.2% in Q1 2025.